Presentation

Poster

June

 

14

2025

EHA 2025: ALK1-BMPRII Receptor Agonism Treats Vascular Pathology in Hereditary Hemorrhagic Telangiectasia Models

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.